title: Bin1 Antibodies for IBD Therapy: Is Permeability the Answer BAR None?
authors.affiliation: Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Dragana, 68100, Alexandroupolis, Greece. gkolios@med.duth.gr.
authors.forename: George
authors.initials: G
authors.lastname: Kolios
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003092:Colitis / Q000628:therapy*; D006801:Humans; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors*; D009687:Nuclear Proteins / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000911:Antibodies, Monoclonal; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D025521:Tumor Suppressor Proteins